结论：将抗结核药利福平制备成微球制剂，肺部分可提高药物在肺部的分布，静注后无明显不良反应。
CONCLUSION: the lung tissue pulmonary distribution rate of rifampin may be promoted by making rifampin into microsphere dosage form and there were no significant side effects.
结论：将抗结核药利福平制备成微球制剂，肺部分可提高药物在肺部的分布，静注后无明显不良反应。
CONCLUSION: the lung tissue pulmonary distribution rate of rifampin may be promoted by making rifampin into microsphere dosage form and there were no significant side effects.
应用推荐